Clinical trials: SLE Nephritis
Lupus Nephritis
Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis
This was an open-label, prospective, single-arm, observational study in patients with Lupus nephritis (LN) who newly (i.e.,for the first time) received treatment of Enteric-coated Mycophenolate Sodium (EC-MPS).
- Trial name
- NCT04645589
- Testing
- Myfortic
- Where
- 6 sites in Taiwan
- Volunteers
- 69 people
- Sponsor
- Novartis Pharmaceuticals